13407
Anti-amyloid Therapy Safety In The Real World: A Comparison Between Lecanemab And Donanemab Across Three Institutions
Michael Rosenbloom, David Weisman, Ryan Townley, Andrea Schnee, Alvine Martin, Emanuele Camarucci, Helen Lutz, Jordyn Kelman, Kala Zingle, Daniel Fisher
University of Washington, University of Kansas, Abington Neurological Associates
Poster Presenter: Michael Rosenbloom